Letter Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease1 MAG-G and JL are senior authors 2 Division of Rheumatology, Hospital Xeral Calde, c) Dr Ochoa s/n, 27004, Lugo, Spain 3 Division of Cardiology, Hospital Xeral Calde, c) Dr Ochoa s/n, 27004, Lugo, Spain 4 Consejo Superior de Investigaciones Cientificas, Avenida del Conocimiento s/n, 18100, Armilla, Granada, Spain 5 Division of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, Avda. Cardenal Herrera Oria s/n, 39011, Santander, Spain 6 CIBER Epidemiología y Salud Pública (CIBERESP), Spain
Arthritis Research & Therapy 2008, 10:403doi:10.1186/ar2409
See related editorial by Veldhuijzen van Zanten and Kitas, http://arthritis-research.com/content/10/1/102 and related response by Veldhuijzen van Zanten and Kitas, http://arthritis-research.com/content/10/3/404 First paragraph (this article has no abstract)We read with interest the editorial by Veldhuijzen van Zanten and Kitas [1], in which they consider whether carotid artery intima-media thickness (IMT) – a surrogate marker of atherosclerosis – might be a good predictor of future cardiovascular events in patients with rheumatoid arthritis (RA). They state that it remains an open question, because no long-term studies have documented such an association in patients with RA. We are pleased to provide the readers of this journal with an answer to this question. |




on Google Scholar







author email
corresponding author email